Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 6,067,600 | 5,439,500 | 5,010,000 | 4,464,000 | 5,232,500 |
| Cost of Goods | 1,334,200 | 1,117,500 | 978,400 | 723,700 | 1,248,900 |
| Gross Profit | 4,733,400 | 4,322,000 | 4,031,600 | 3,740,300 | 3,983,600 |
| Operating Expenses | 3,469,400 | 2,943,800 | 2,723,100 | 2,242,600 | 2,294,200 |
| Operating Income | 1,264,200 | 1,378,700 | 1,308,900 | 1,498,400 | 1,690,300 |
| Interest Expense | 0 | 19,800 | 17,600 | 19,200 | 18,400 |
| Other Income | 8,700 | 189,200 | 81,100 | 40,300 | 30,100 |
| Pre-tax Income | 1,272,900 | 1,548,100 | 1,372,400 | 1,519,500 | 1,702,000 |
| Income Tax | 216,900 | 152,100 | 152,400 | 195,500 | 198,900 |
| Net Income Continuous | 1,056,000 | 1,396,000 | 1,220,000 | 1,324,000 | 1,503,100 |
| Net Income Discontinuous | 13,400 | 2,773,700 | 179,400 | 197,900 | N/A |
| Minority Interests | -4,100 | -4,900 | -3,000 | 0 | N/A |
| Net Income | $1,073,500 | $4,174,600 | $1,402,400 | $1,521,900 | $1,503,100 |
| EPS Basic Total Ops | 1.84 | 6.98 | 2.31 | 2.46 | 2.41 |
| EPS Basic Continuous Ops | 1.81 | 2.34 | 2.02 | 2.14 | 2.41 |
| EPS Basic Discontinuous Ops | 0.03 | 4.64 | 0.29 | 0.32 | N/A |
| EPS Diluted Total Ops | 1.83 | 6.97 | 2.30 | 2.44 | 2.38 |
| EPS Diluted Continuous Ops | 1.81 | 2.34 | 2.01 | 2.12 | 2.38 |
| EPS Diluted Discontinuous Ops | 0.02 | 4.63 | 0.29 | 0.32 | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | 2.43 | 2.51 | 2.48 | 2.22 |
| EBITDA(a) | $1,264,200 | $1,533,900 | $1,453,800 | $1,638,000 | $1,825,100 |